The Unmeasured Variable in Cannabis Cardiovascular Research: Intracellular Magnesium and Electrical Reserve

By Chris Junge, Founder, Solprana · B.S. Biomedical Science · Updated October 20, 2026

Every heartbeat begins as an electrical event. Before cardiac muscle contracts, sodium, potassium, and calcium ions move across cell membranes through channels that open and close in a precise sequence, driven by concentration gradients that ATP-dependent pumps maintain continuously. Nerve conduction, vascular tone, muscle contraction, and mitochondrial energy production all rest on the same principle of controlled ion movement. This is established physiology, and it is the frame through which this article approaches an open question about cannabis and the heart.

The heart as an electrical organ

The heart is usually described as a pump, and mechanically it is one. It is also an electrical organ whose stability depends on the balance of inward and outward currents during each action potential. Sodium entry initiates depolarization, calcium entry sustains the plateau and triggers contraction, and several potassium currents return the cell to rest. Electrophysiologists describe the redundancy among those repolarizing currents as repolarization reserve (Varró and Baczkó, 2011). A healthy heart can lose part of one current without consequence because others compensate. When several are reduced at once, a second stressor such as a catecholamine surge, an electrolyte shift, or a rapid heart rate can expose a vulnerability that was invisible at rest. This concept matters because many cardiac events occur not during rest but during load.

What is known about cannabis and the heart

The clearest human signal concerns acute exposure. In a case-crossover study of 3,882 patients, the risk of myocardial infarction was 4.8 times higher in the hour after marijuana use than at other times (Mittleman et al., 2001). The estimate rests on nine patients who used within that hour, which is why the confidence interval runs from 2.4 to 9.5 and why the authors described marijuana as a rare trigger of infarction rather than a common one. Survey-based analyses associate more frequent use with higher odds of coronary disease, infarction, and stroke, including among people who have never used tobacco (Jeffers et al., 2024), and a 2025 meta-analysis reported elevated risks across outcomes while rating most included studies at moderate to high risk of bias (Storck et al., 2025). The evidence is not uniform. The CARDIA cohort found no association between cumulative lifetime use and incident cardiovascular disease through middle age (Reis et al., 2017), and a 2026 randomized crossover study of regular users found fewer premature atrial beats on cannabis-use days (Elias et al., 2026). The literature supports an acute trigger effect more firmly than a chronic one, and it leaves mechanism largely unresolved.

Cannabinoids and ion channels

Cannabinoids act beyond the CB1 and CB2 receptors. In laboratory systems, endocannabinoids block cardiac potassium channels that shape early repolarization through receptor-independent mechanisms (Amorós et al., 2010). Cannabidiol inhibits voltage-gated sodium channels, including the cardiac isoform (Ghovanloo et al., 2018), reduces calcium signaling in ventricular myocytes (Ali et al., 2015), and inhibits the channel complex responsible for IKs, the potassium current that shortens repolarization during sympathetic stimulation (Kusay et al., 2026). Case reports describe cannabis-associated unmasking of the Brugada electrocardiographic pattern, consistent with sodium-channel relevance in susceptible individuals. These findings are real, but most occur at micromolar concentrations in isolated cells, and whether cardiac tissue in regular users reaches those concentrations is not known. They establish that cannabinoids can interact with the machinery of cardiac rhythm. They do not establish that they do so meaningfully in people.

Magnesium inside the cell

Magnesium is one of the most abundant intracellular cations, and almost all of it resides in bone, muscle, and soft tissue rather than in the blood (de Baaij et al., 2015). Serum magnesium represents a small fraction of body stores and is held within a narrow range by the kidney, so a normal serum value does not exclude tissue depletion (Elin, 2010; Costello et al., 2016). In one direct comparison, magnesium measured in sublingual epithelial cells correlated with magnesium in atrial tissue, whereas serum magnesium did not (Haigney et al., 1995). Red blood cell magnesium, ionized magnesium, urinary excretion, and magnesium retention after an intravenous load each add information, and each has limitations. Phosphorus-31 magnetic resonance spectroscopy can estimate free intracellular magnesium in muscle and brain in research settings. No routine clinical test measures intracellular magnesium in the human heart.

Why Mg-ATP connects energy and electrical stability

Inside cells, ATP functions largely as a complex with magnesium, and magnesium participates in regulating mitochondrial respiration and ATP production (Gout et al., 2014). The pumps that restore ion gradients after every beat, including the sodium-potassium ATPase and the calcium pump of the sarcoplasmic reticulum, consume Mg-ATP. Intracellular magnesium also shapes ion currents directly: it blocks the inward rectifier potassium channel from inside the cell, producing the rectification that stabilizes resting potential (Matsuda et al., 1987), and it inhibits the L-type calcium current (Wang et al., 2004). ATP-sensitive potassium channels respond to the balance of Mg-ATP and Mg-ADP and act as sensors of cellular energy state (Nichols, 2006). Magnesium deficiency promotes renal potassium loss (Huang and Kuo, 2007), and magnesium-deficient animals develop arrhythmias accompanied by reduced calcium channel expression (Shimaoka et al., 2015). Magnesium therefore sits at the junction of energy supply and electrical stability, which is why its absence from a line of cardiovascular research deserves attention.

Exercise as the test condition

Exercise is the physiological condition that asks the most of this system. Heart rate, contractility, catecholamine levels, ATP turnover, and calcium cycling all rise. Potassium shifts between muscle and blood (Paterson, 1996), and circulating magnesium falls after prolonged exercise before recovering over several hours (Terink et al., 2017). The repolarization current IKs is increased by sympathetic stimulation, which is why exercise is the characteristic trigger of arrhythmia when that current is genetically impaired (Schwartz et al., 2001). Vigorous exertion transiently raises the risk of sudden cardiac death and myocardial infarction in the general population, an effect that is much smaller in people who exercise regularly (Albert et al., 2000; Mittleman et al., 1993). Exercise also raises the magnesium requirement itself, by something on the order of 10 to 20 per cent in people training strenuously, through losses in sweat and urine (Nielsen and Lukaski, 2006). That requirement is not theoretical: when postmenopausal women were fed 150 rather than 320 mg of magnesium per day under controlled conditions, heart rate and oxygen consumption during submaximal exercise both rose, meaning the same workload cost more cardiac work at the lower intake (Lukaski and Nielsen, 2002). If electrical reserve is reduced, exercise is where that reduction would become measurable.

The direct human evidence on cannabis and exercise remains small. In men with stable angina, smoking marijuana shortened the time to exercise-induced chest pain compared with placebo (Aronow and Cassidy, 1974). In nine trained young adults, a 10 mg edible THC dose did not change cycling performance or cardiorespiratory responses (Ewell et al., 2022). A 2025 study measured cardiovascular responses during and after maximal cycling under four cannabis exposure conditions and found that the differences appeared in recovery rather than during exercise: smoked THC-predominant cannabis raised post-exercise pulse pressure and altered a measure of systolic function, while vascular responses and exercising blood pressure were unchanged, and CBD-predominant cannabis showed neither effect (Cheung et al., 2025). That study measured echocardiography and hemodynamics rather than electrical behavior, which is precisely the gap this hypothesis addresses.

The hypothesis

The hypothesis can be stated plainly. In individuals whose intracellular magnesium status is marginal, cannabis-related changes in ion-channel activity, autonomic tone, or cellular energetics could narrow cardiac electrical reserve in ways that become apparent under physiological stress such as exercise. Three versions of this idea should be kept separate, because they are not equally supported and they do not predict the same measurements. In the first, cannabis depletes intracellular magnesium stores; there is currently no human evidence for this, and it is not the claim advanced here. In the second, cannabinoid exposure adds to the demands competing for an unchanged intracellular pool, so that the magnesium required to maintain homeostasis under load rises without stores having fallen. A measured status within the reference range and an elevated requirement are not mutually exclusive, and requirement in cannabis users has not been measured. In the third, magnesium status determines how well the heart tolerates the electrophysiological effects of cannabis. The second and third formulations are the defensible ones, because they rest on documented channel overlap and on the distinction between stores and reserve rather than on a depletion effect for which no human evidence exists.

This integrated pathway has not been demonstrated. No published study has measured intracellular magnesium in cannabis users alongside cardiac electrophysiology, at rest or during exercise. The only direct cannabinoid–magnesium interaction data identified are behavioral findings in rats fed magnesium-deficient diets (Bac et al., 2002), which cannot be extended to the human heart.

That absence of evidence has a partial explanation. The cannabis cardiovascular studies reviewed for this work did not measure magnesium of any kind, and the population research linking magnesium to arrhythmia relies largely on serum values, which are poorly suited to detecting tissue depletion. A variable that is not measured cannot be found, and it also cannot be excluded.

Other explanations deserve equal weight

A magnesium-dependent mechanism would have to compete with explanations that currently have stronger support. The acute rise in heart rate after THC increases myocardial oxygen demand, which is sufficient to explain earlier ischemia in people with coronary disease. Endothelial function is lower in regular smokers and edible users than in non-users (Mohammadi et al., 2025), and in animal studies smoke from cannabis without cannabinoids also impaired vascular function, implicating combustion itself (Wang et al., 2016). THC increases platelet activation markers in vitro (Deusch et al., 2004). Smoking marijuana raises carboxyhemoglobin more than smoking tobacco (Wu et al., 1988). Coronary vasospasm, underlying plaque, inherited channelopathies, co-use of tobacco or other substances, adulterated products, and electrolyte losses from repeated vomiting are all documented or plausible contributors. Cannabis is also not a single exposure: tolerance develops to many of its cardiovascular effects with regular use (Benowitz and Jones, 1975), and cannabidiol can lower blood pressure (Jadoon et al., 2017). Magnesium may interact with several of these pathways rather than stand apart from them, since magnesium deficiency independently promotes coronary spasm in isolated arteries (Turlapaty and Altura, 1980).

The question that remains

The more useful question may not be whether cannabis is good or bad for the heart, but whether current studies are measuring the variables that would reveal who is at risk, under what conditions, and through which mechanism. Are we measuring the right variables when we study cardiovascular risk in cannabis users? Should intracellular magnesium, Mg-ATP biology, ion-channel regulation, and cardiac electrical reserve be included in future cannabis cardiovascular studies? A study that measured cannabinoid exposure beyond THC, magnesium status beyond serum, and repolarization behavior during and after exercise could answer that question directly. It could also refute the hypothesis, and that outcome would be equally informative.

---

---

References

1. Albert CM, Mittleman MA, Chae CU, et al. Triggering of sudden death from cardiac causes by vigorous exertion. New England Journal of Medicine. 2000;343(19):1355–1361. doi:10.1056/NEJM200011093431902 · PubMed
2. Ali RM, Al Kury LT, et al. Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. Cell Calcium. 2015. PubMed
3. Amorós I, Barana A, Caballero R, et al. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner. Journal of Molecular and Cellular Cardiology. 2010;48(1):201–210. PubMed
4. Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. New England Journal of Medicine. 1974;291(2):65–67. doi:10.1056/NEJM197407112910203 · PubMed
5. Bac P, Pages N, Herrenknecht C, et al. THC aggravates rat muricide behavior induced by two levels of magnesium deficiency. Physiology and Behavior. 2002;77(2-3):189–195. doi:10.1016/S0031-9384(02)00813-2 · PubMed
6. Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clinical Pharmacology and Therapeutics. 1975;18(3):287–297. PubMed
7. Cheung CP, et al. The acute cardiovascular response to dynamic exercise and recovery following cannabis use. American Journal of Physiology – Heart and Circulatory Physiology. 2025. doi:10.1152/ajpheart.00608.2025 · PubMed
8. Costello RB, Elin RJ, Rosanoff A, et al. Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come. Advances in Nutrition. 2016;7(6):977–993. PubMed
9. de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiological Reviews. 2015;95(1):1–46. doi:10.1152/physrev.00012.2014 · PubMed
10. Deusch E, Kress HG, Kraft B, Kozek-Langenecker SA. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesthesia and Analgesia. 2004;99(4):1127–1130. PubMed
11. Elias A, Montenegro GC, Oo HH, et al. Acute effects of cannabis inhalation on cardiac ectopy, physical activity, sleep, and glucose. Journal of the American College of Cardiology. 2026. doi:10.1016/j.jacc.2026.07.014
12. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnesium Research. 2010;23(4):S194–S198. PubMed
13. Ewell TR, Bomar MC, Abbotts KSS, et al. Edible marijuana and cycle ergometer exercise. Frontiers in Physiology. 2022;13:1085822. doi:10.3389/fphys.2022.1085822 · PubMed
14. Ghovanloo MR, Shuart NG, Mezeyova J, et al. Inhibitory effects of cannabidiol on voltage-dependent sodium currents. Journal of Biological Chemistry. 2018;293(43):16546–16558. PubMed
15. Gout E, Rébeillé F, Douce R, Bligny R. Interplay of Mg2+, ADP, and ATP in the cytosol and mitochondria: unravelling the role of Mg2+ in cell respiration. Proceedings of the National Academy of Sciences USA. 2014;111(43):E4560–E4567. doi:10.1073/pnas.1406251111 · PubMed
16. Haigney MC, et al. Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation. 1995;92(8):2190–2197. doi:10.1161/01.CIR.92.8.2190 · PubMed
17. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. Journal of the American Society of Nephrology. 2007;18(10):2649–2652. doi:10.1681/ASN.2007070792 · PubMed
18. Jadoon KA, Tan GD, O’Sullivan SE. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight. 2017;2(12):e93760. doi:10.1172/jci.insight.93760 · PubMed
19. Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. Journal of the American Heart Association. 2024;13(5):e030178. doi:10.1161/JAHA.123.030178 · PubMed
20. Kusay AS, Pökl M, Hiniesto-Iñigo I, Sridhar A, Delemotte L, Liin SI. Cannabidiol inhibits both human KV7.1 and KV7.1/KCNE1 channels through distinct sites. Acta Pharmacologica Sinica. 2026;47(7):1825–1839. doi:10.1038/s41401-025-01742-0 · PubMed
21. Lukaski HC, Nielsen FH. Dietary magnesium depletion affects metabolic responses during submaximal exercise in postmenopausal women. Journal of Nutrition. 2002;132(5):930–935. PubMed
22. Matsuda H, Saigusa A, Irisawa H. Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature. 1987;325(7000):156–159. PubMed
23. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–2809. doi:10.1161/01.cir.103.23.2805 · PubMed
24. Mittleman MA, Maclure M, Tofler GH, et al. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. New England Journal of Medicine. 1993;329(23):1677–1683. PubMed
25. Mohammadi L, Navabzadeh M, Jiménez-Téllez N, et al. Association of endothelial dysfunction with chronic marijuana smoking and THC-edible use. JAMA Cardiology. 2025;10(8):851–855. doi:10.1001/jamacardio.2025.1399 · PubMed
26. Nichols CG. KATP channels as molecular sensors of cellular metabolism. Nature. 2006;440(7083):470–476. doi:10.1038/nature04711 · PubMed
27. Nielsen FH, Lukaski HC. Update on the relationship between magnesium and exercise. Magnesium Research. 2006;19(3):180–189. PubMed
28. Paterson DJ. Role of potassium in the regulation of systemic physiological function during exercise. Acta Physiologica Scandinavica. 1996;156(3):287–294. PubMed
29. Reis JP, Auer R, Bancks MP, et al. Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study. American Journal of Public Health. 2017;107(4):601–606. doi:10.2105/AJPH.2017.303654 · PubMed
30. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103(1):89–95. PubMed
31. Shimaoka T, Wang Y, Morishima M, Miyamoto S, Ono K. Hypomagnesemic down-regulation of L-type Ca2+ channel in cardiomyocyte as an arrhythmogenic substrate in rats. Pathophysiology. 2015;22(2):87–93. doi:10.1016/j.pathophys.2015.01.002 · PubMed
32. Storck W, et al. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis. Heart. 2025. doi:10.1136/heartjnl-2024-325429 · PubMed
33. Terink R, Balvers MGJ, Hopman MT, Witkamp RF, Mensink M, Klein Gunnewiek JMT. Decrease in ionized and total magnesium blood concentrations in endurance athletes following an exercise bout restores within hours: potential consequences for monitoring and supplementation. International Journal of Sport Nutrition and Exercise Metabolism. 2017;27(3):264–270. doi:10.1123/ijsnem.2016-0284 · PubMed
34. Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science. 1980;208(4440):198–200. doi:10.1126/science.7361117 · PubMed
35. Varró A, Baczkó I. Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk. British Journal of Pharmacology. 2011;164(1):14–36. doi:10.1111/j.1476-5381.2011.01367.x · PubMed
36. Wang M, Tashiro M, Berlin JR. Regulation of L-type calcium current by intracellular magnesium in rat cardiac myocytes. Journal of Physiology. 2004;555(Pt 2):383–396. doi:10.1113/jphysiol.2003.048538 · PubMed
37. Wang X, Derakhshandeh R, Liu J, et al. One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function. Journal of the American Heart Association. 2016;5(8):e003858. doi:10.1161/JAHA.116.003858 · PubMed
38. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. New England Journal of Medicine. 1988;318(6):347–351. doi:10.1056/NEJM198802113180603 · PubMed

Chris Junge is the founder of Solprana, a research-first nutrition company. Solprana produces magnesium-containing nutritional products, a commercial interest in the subject of this article that readers should weigh when assessing it. This article describes a research hypothesis. It is not medical advice and makes no claim that any product prevents or treats cardiovascular disease.